Pulmotherapeutics Inc
New Form D on file · 2025-04-14 · the record
Before you sell to, join or invest in Pulmotherapeutics Inc
MentionFox check on Pulmotherapeutics Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/pulmotherapeutics-inc-form-d-25000001
Check Pulmotherapeutics Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Pulmotherapeutics Inc?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Pulmotherapeutics Inc filed a Form D with the Securities and Exchange Commission on 2025-04-14.
Pulmotherapeutics Inc filed a Form D notice of an exempt securities offering with the SEC on April 14, 2025. The filing reports $500K sold. Its industry group is Biotechnology. It names Nagarjun Konduru Venkata (Executive Officer, Director) (SEC Form D, April 14, 2025).
Is this your company?
Sell to companies like Pulmotherapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pulmotherapeutics Inc.
Free to see. No signup.
More on the people and the money behind Pulmotherapeutics Inc, from the filings we hold.
Biotechnology raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when Pulmotherapeutics Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Pulmotherapeutics Inc raises, hires or launches. No email unless you switch it on.
Watch Pulmotherapeutics Inc →Get the full cited report on Pulmotherapeutics Inc
What the filing shows about Pulmotherapeutics Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pulmotherapeutics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Pulmotherapeutics Inc's address as 714 Huntwick Ln, Tyler, TX 75703.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Pulmotherapeutics Inc is a registered filer with the SEC (CIK 2064557) and has filed since 2025-04-14. 1 filing is on record, the latest on 2025-04-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Pulmotherapeutics Inc's Form D of 2025-04-14 names Nagarjun Konduru Venkata as its officers, directors or promoters.
Its new offerings report $500K sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
The Chief Executive Officer would receive an estimated salary of $250,000
Nagarjun Konduru Venkata is named as Executive Officer and Director on the Form D that Pulmotherapeutics Inc filed with the SEC on 14 April 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-04-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Pulmotherapeutics Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pulmotherapeutics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pulmotherapeutics Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pulmotherapeutics IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Pulmotherapeutics Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Pulmotherapeutics Inc. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/pulmotherapeutics-inc-form-d-25000001